Iovance Biotherapeutics, Inc. (1IOVA)
Market Closed
17 Jul, 15:30
€
4. 28
-0.02
-0.4657%
€
885.24M Market Cap
- P/E Ratio
- Div Yield
1,944 Volume
-1.87 Eps
€ 4.29
Previous Close Want to track 1IOVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Iovance Biotherapeutics, Inc. (1IOVA) Statistics
Valuation metrics
Market Cap 885.24M
Enterprise value 955.69M
Trailing P/E (ttm) -3.24
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) 4.82
Price/Book (mrq) 2.17
Enterprise Value/Revenue 3.89
Enterprise Value/EBITDA -3.46
Overview
Shares outstanding 438.11M
Float 387.98M
Shares short -
% Held by insiders 0%
% Held by institutions 0.67%
Average volume (10 days) 1.18K
Average volume (90 days) 795
Price summary
52-Week low 1.51
52-Week high 4.71
Beta 0.69
50-Day moving average 3.13
200-Day moving average 2.38
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.24%
Operating margin -1.13%
Operational effectiveness
Return on assets -0.24%
Return on equity -0.48%
Income Statement
Revenue (ttm) 245.51M
Revenue per share (ttm) 0.75
Quarterly revenue growth (yoy) 0.45%
Gross profit (ttm) 96.83M
EBITDA -276.46M
Net income to common (ttm) -304.17M
Diluted EPS (ttm) -0.79
Quarterly earnings growth (yoy) 0.45%
Balance Sheet
Total cash (mrq) 269.43M
Total cash per share (mrq) 0.7
Total debt (mrq) 41.07M
Total Debt/Equity (mrq) 6.62
Current ratio (mrq) 3.6%
Book value per share (mrq) 1.42
Cash Flow
Cash flow statement -232.77M
Levered free cash flow (LFCF) -128.14M
